(Submitted for publication February 14, 1962 ; accepted July 12, 1962) The susceptibility of patients with Hodgkin's disease to mycotic and viral infections has long directed attention to an immunological defect in that condition (1) . The early finding of tuberculin negativity in these patients (2, 3) , even in the presence of active tuberculous infection, has been confirmed repeatedly. Subsequent investigations have indicated that this cutaneous anergy extends to many other allergens mediated by the delayed or cellular type of hypersensitivity mechanism (4) (5) (6) (7) (8) (9) (10) (11) . Recently, the demonstration of tolerance to skin homografts in some patients with Hodgkin's disease (12) has further emphasized the extent of the immunological defect.
The purpose of the present communication is to inquire how intimately, and with what consistency, loss of the delayed type of hypersensitivity is associated with Hodgkin's disease and to pose certain questions regarding the causal relationships. Dinitrochlorobenzene (13, 14) , a compound which uniformly induces hypersensitivity in normal individuals, has been used in the present investigation to study cutaneous anergy in 37 patients with Hodgkin's disease. Unlike the earlier methods of study, the use of dinitrochlorobenzene permits the evaluation of the state of the delayed sensitivity mechanism in the individual Hodgkin's patient. Several previous investigators (15) (16) (17) have studied small groups of patients with Hodgkin's disease and other lymphomas by this method; the present study is the first extensive study of this disease with a technique of active sensitization and the first in which the results have been correlated with the activity of the disease. In the present experiments, active Hodgkin's disease was always found to be associated with a loss of delayed hypersensitivity, whereas normal cutaneous sensitivity was found in all patients whose disease had been inactive for more than two years.
MATERIALS AND METHODS
Selection and classification of patients. Only patients with histologically verified Hodgkin's disease were studied. In most instances the histologic material for the present study was reviewed by a member of the Pathol- t Under this heading is given the manifestation of the disease and the date when it was active in patients with inactive disease when tested.
: Hodgkin's paragranuloma. § Negative to 1 mg of old tuberculin in the presence of active tuberculosis.
present and unchanged for 3 and 5 years, respectively. significant adenopathy (2-to 3-cm nodes) at the time Patients classified as active had at least one of the mani-of testing. In the few instances where the clinical findfestations listed in Table I In preliminary studies this erythema was evaluated in 10 unsensitized normal subjects. In the unsensitized, the redness is never more than moderately intense and does not occupy the entire area of application, rarely being more than an incomplete rim. Furthermore, the erythema of the unsensitized individual is well developed by 24 hours, no more intense at 2 days, has faded markedly by 4 For retesting, only the eliciting concentration (0.1 per cent) is applied. This concentration will also sensitize over 60 per cent of normal individuals (13, 14) .
RESULTS
The results of 60 tests of cutaneous sensitivity in 37 patients with Hodgkin's disease are presented in Table I. This table also Twelve patients were studied only when their disease was inactive and had been so for 1 to 29 years. All had normal skin sensitivity except one (Case 32), whose disease was inactive for 18 months. Three patients were studied when their disease was active (anergic) and again at subsequent periods of quiescence and activity (Cases 7, 8, and 10). One of these (Case 10) showed an equivocal reaction one month after his disease became inactive and had recovered his skin sensitivity when tested 4 months after control of his disease. Case 8 remained anergic for 8 months after treatment of his disease by radiation, developed a positive skin test at 9 months, but again became anergic 3 months later when his cervical adenopathy recurred. Case 7 had two remissions in disease activity lasting 3 and 4 months respectively, each terminated by return of active disease. The patient remained anergic throughout the period of observation.
DISCUSSION
Over the past three decades there have been many studies of the delayed type of hypersensitivity in patients with Hodgkin's disease. For the most part these studies have consisted of skintesting patients with tuberculin and other allergens causing delayed reactions (extracts of trichophytin, histoplasmin, candida albicans, mumps, streptokinase-streptodornase, and diphtheria toxoid) and comparing the Hodgkin's group with a normal control group. Results of these studies have consistently revealed a much lower incidence of positive skin reactions in the Hodgkin's patients than in the normal controls (2-11). Studies of this type suffer from two serious limitations. The first is that rarely do more than 50 per cent of the normal controls react to a particular antigen, and frequently the percentage is much smaller. Thus, the results of such studies permit a conclusion to be drawn about individuals with Hodgkin's disease as a group, but allow no conclusion about the individual patient. A particular patient may not react either because he is anergic or because he has never been exposed to the antigen. The second shortcoming of this type of study is the failure to note the clinical state of the patient when tested. The course of Hodgkin's disease is extremely varied. The failure to distinguish a patient whose initial enlarged cervical lymph node has been followed by 30 years of complete health from a patient with florid generalized disease only obscures significant findings. Clearly, normal immune responses in the two patients have different implications about the importance of immune mechanisms in the disease process.
Several recent studies have been done which obviate, in part, the first of the above objections. Kelly, Good, Varco, and Levitt (7, 8) have reported their inability to induce hypersensitivity to diphtheria toxoid in nine patients with Hodgkin's disease. However, only nine of 13 normal controls became sensitized with the technique they employed. Kelly, Lamb, Varco, and Good (12) have also reported a delayed homograft rejection in 10 of 17 Hodgkin's patients, whereas the graft in three additional patients behaved like autografts. We feel that the complexity of the homograft reaction (18, 19) makes it a relatively unsatisfactory technique to use in the evaluation of the anergic state of the Hodgkin's patient. BCG vaccination (9) has been reported to induce tuberculin positivity in 10 of 12 tuberculin negative Hodgkin's patients without systemic manifestations, but in none of three patients with systemic manifestations.
The induction of skin sensitivity with a delayed contact allergen such as dinitrochlorobenzene would appear to be a very satisfactory way of studying the anergic state of the Hodgkin's patient. Epstein and Kligman (13, 14) report that a single application of dinitrochlorobenzene sensitizes over 90 per cent of a large series of normal controls. Our 10 normal controls were uniformly sensitized, and we therefore feel that this is indeed a valuable technique for studying delayed sensitivity. Furthermore, repeated testing with this technique is possible; the eliciting application itself serves to sensitize over 60 per cent of normal individuals. With this technique several previous groups of investigators, in prelimi-nary reports, have studied small groups of patients with Hodgkin's disease and leukemia (15) (16) (17) . In these studies, the number of patients with Hodgkin's disease has been small (4 to 5 cases), the results in Hodgkin's patients have not been separated from other lymphomas, and no clinical information has been given. No comprehensive investigations employing DNCB in Hodgkin's patients have been reported.
Using the technique of dinitrochlorobenzene sensitization, we have been impressed with the regularity of cutaneous anergy in patients with active Hodgkin's disease. In the present series all 25 patients with active disease were anergic. Nine patients whose disease was inactive for periods of more than 2 years displayed normal skin reactions, whereas in six whose disease was inactive for periods of less than 2 years, the reactions were either normal or anergic. Our data are not sufficient to permit us to be certain either that all our inactive patients were anergic when their disease was active, or that all patients with active Hodgkin's disease are anergic. In particular, our data are inadequate with regard to two variants of Hodgkin's disease, the paragranuloma type (no active and three inactive cases in our series) and disease localized to a single lymph node group (two active and seven inactive cases). We have observed, however, the transition from depressed to normal skin sensitivity, coincident with response of local disease to radiation, in two individuals and the opposite transition with activation of disease in one patient, indicating that these transitions do occur. [Sokal and Primikirios (9) have observed the recovery of tuberculin sensitivity with remission of Hodgkin's disease in two patients.] From our data, we can infer that it takes from several months to several years for the recovery of skin sensitivity after the disappearance of clinical activity. It appears likely that a number of our inactive patients with normal skin sensitivity were anergic when their disease was active. That this was true of the entire group is an attractive but unproven hypothesis.
It is well known that severely debilitating diseases (9) and the acute febrile stage of several infectious viral diseases (20) In our opinion, it seems most plausible to assume that the Hodgkin's disease process, even when clinically localized, can cause a suppression of delayed hypersensitivity. The recovery of skin sensitivity we and others (9) have observed after local radiation favors this sequence. Where in the complex and poorly understood process of delayed sensitivity this block takes place, and whether the block is mediated by a humoral agent or cells, is speculative. Another possibility is that the immunologic defect results from disease involvement of some unknown site necessary for immune responsiveness. In this connection the accumulating evidence for an immunologic role of the thymus (24, 25) and the proposed (26) but disputed (27) thymic origin of Hodgkin's disease should be mentioned. Finally, the possibility should be considered that the immunologic defect is primary (perhaps a biochemical defect of a particular cell type), and glandular enlargement of the specific cellular pattern that characterizes Hodgkin's disease is a secondary reactive event (1) .
Many serious students of the disease have not been convinced of the neoplastic nature of Hodgkin's granuloma (28) . A viral etiology has been repeatedly proposed but never established (29) , and an immunologic mechanism involving a graftversus-host reaction has been recently suggested (30, 31) . Although the significance of the cutaneous anergy of Hodgkin's disease remains to be established, it should be explained by a satisfactory disease mechanism.
SUMMARY
Delayed hypersensitivity has been studied in 37 patients with Hodgkin's disease by means of active sensitization with dinitrochlorobenzene. In the presence of active Hodgkin's disease, even when clinically localized, cutaneous anergy was consistently found, and in two patients anergy fluctuated with the activity of the disease. Patients whose Hodgkin's disease was inactive for two years or longer had normal skin reactivity, whereas those whose disease was inactive for less than two years showed either anergy or a normal reaction. A close association of active Hodgkin's granuloma and an immunologic defect characterized by cutaneous anergy is clear from these studies. The significance of this association remains to be established.
